The UK has approved a CRISPR disease treatment, reportedly becoming the first country to do so. The treatment appears to be aimed at diseases such as sickle cell disease and beta thalassemia, although its potential application to other conditions, like HIV, is also being considered. The approval marks a significant development in gene therapy, with the treatment potentially offering a cure for certain diseases.